Literature DB >> 20383850

Choroidal metastasis with adenocarcinoma of the lung treated with gefitinib.

Maiko Inoue1, Yoichiro Watanabe, Shin Yamane, Satoshi Kobayashi, Akira Arakawa, Toshinori Tsukahara, Takeshi Kaneko, Kazuaki Kadonosono.   

Abstract

PURPOSE: To report a case of bilateral regression of choroidal metastasis with adenocarcinoma of the lung treated with gefitinib.
METHODS: Retrospective case review of a 68-year-old woman with pulmonary adenocarcinoma with choroidal metastasis who presented with visual loss in the left eye as the initial manifestation. Her visual acuity was 6/6 in the right eye and 6/60 in the left eye before the start of gefitinib administration. Best-corrected visual acuity and spectral-domain optical coherence tomography were compared between baseline and 3 months after treatment.
RESULTS: Best-corrected visual acuity in the left eye had improved to 6/30 3 months after oral gefitinib. The elevated lesions of the right eye disappeared, with decrease of subretinal fluid and retinal pigment epithelial atrophy. Spectral-domain optical coherence tomography showed that subretinal fluid of the left eye was also reduced.
CONCLUSIONS: Oral gefitinib could be effective for regression of choroidal metastasis in patients with adenocarcinoma of the lung and provides a potential treatment option.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20383850     DOI: 10.1177/112067211002000526

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  6 in total

1.  Tyrosine Kinase Inhibitors in the Treatment of Choroidal Metastases from Non-Small-Cell Lung Cancer: A Case Report and Review of Literature.

Authors:  Akshay Gopinathan Nair; Haresh T Asnani; Vinod C Mehta; Siddharth V Mehta; Rima S Pathak; Amit H Palkar; Indumati Gopinathan
Journal:  Ocul Oncol Pathol       Date:  2016-09-14

2.  Blurred vision as the sole initial presentation of disseminated lung malignancy.

Authors:  Mary K Jacob; Cecil Pinheiro; Prasad George; Zafar A Zaidi
Journal:  Saudi J Ophthalmol       Date:  2013-08-06

Review 3.  Targeted Lung Cancer Treatments and Eye Metastasis.

Authors:  Paul Zarogoulidis; Sofia Baka; Sofia Labaki; George Lazaridis; Georgia Trakada
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2017

4.  Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer and Eye Metastasis: Disease Relapse or a New Entity?

Authors:  Paul Zarogoulidis; Sofia Lampaki; Panos Chinelis; George Lazaridis; Sofia Baka; Aggeliki Rapti
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2016

5.  Epidermal growth factor receptor-mutant non-small cell lung Cancer and Choroidal metastases: long-term outcome and response to epidermal growth factor receptor tyrosine kinase inhibitors.

Authors:  Clémentine Bouchez; Johan Pluvy; Ghassen Soussi; Marina Nguenang; Solenn Brosseau; Morgan Tourne; Mégane Collin; Nathalie Théou-Anton; Alice Guyard; Jamila Ammar; Antoine Khalil; Gérard Zalcman; Valérie Gounant
Journal:  BMC Cancer       Date:  2020-12-03       Impact factor: 4.430

6.  Choroidal metastasis of non-small cell lung cancer that responded to gefitinib.

Authors:  Iwao Shimomura; Yuji Tada; Gen Miura; Toshio Suzuki; Takuma Matsumura; Kenji Tsushima; Jiro Terada; Ryota Kurimoto; Emiko Sakaida; Ikuo Sekine; Yuichi Takiguchi; Shuichi Yamamoto; Koichiro Tatsumi
Journal:  Case Rep Ophthalmol Med       Date:  2013-09-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.